MATEO ALAN

Director · 10x Genomics, Inc.

Every open-market stock purchase MATEO ALAN has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where how the prices paid compare to where the stock trades now.

Total bought
$445.6K
Open-market buys
1
Companies
1
Last buy
Feb 21, 2025

Where the buys stand today

All reported buys

DateTickerSharesPriceValueFiling
Feb 21, 202540,000$11.14$445.6KSEC ↗

Get alerted the next time MATEO ALAN — or any insider — buys

We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.

About this data

Figures are parsed from MATEO ALAN's Form 4 filings on SEC EDGAR (CIK 1595244) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.